Literature DB >> 24808534

First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.

Michael L Granda1, Frederick A Schroeder2, Ronald H J Borra2, Nathan Schauer2, Ehimen Aisaborhale2, Alexander R Guimaraes2, Jacob M Hooker3.   

Abstract

The intrarenal dopamine system is important for signaling and natriuresis, and significant dysfunction is associated with hypertension and kidney disease in ex vivo studies. Dopamine receptors also modulate and are modulated by the renin-angiotensin-aldosterone system. Here, we show the first in vivo measurement of D1-like receptors in the renal cortex of Sprague-Dawley rat and Papio anubis baboon using [(11)C]NNC 112, a positron emission tomography radioligand for D1-like receptors. In addition, we show a D1-like binding potential response to angiotensin II blockade in rats using losartan. Demonstration of self-saturable binding in the rat as well as specific and saturable binding in Papio anubis validate the use of [(11)C]NNC 112 in the first in vivo measurement of renal dopamine D1-like receptors. Furthermore, [(11)C]NNC 112 is a radioligand tool already validated for use in probing human central nervous system (CNS) D1-like receptors. Our work demonstrates specific and saturable non-CNS binding in higher animals and the ability to quantify physiological response to drug treatment and provides a clear path to extend use of [(11)C]NNC 112 to study renal dopamine in humans.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  dopamine; hypertension; positron emission tomography; renal PET; renal dopamine

Mesh:

Substances:

Year:  2014        PMID: 24808534      PMCID: PMC4347741          DOI: 10.1152/ajprenal.00111.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  24 in total

1.  Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans.

Authors:  Vanessa L Cropley; Masahiro Fujita; John L Musachio; Jinsoo Hong; Subroto Ghose; Janet Sangare; Pradeep J Nathan; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

2.  Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.

Authors:  C Halldin; C Foged; Y H Chou; P Karlsson; C G Swahn; J Sandell; G Sedvall; L Farde
Journal:  J Nucl Med       Date:  1998-12       Impact factor: 10.057

3.  Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

Authors:  Una D McCann; Zsolt Szabo; Esen Seckin; Peter Rosenblatt; William B Mathews; Hayden T Ravert; Robert F Dannals; George A Ricaurte
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

4.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

Review 5.  Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises.

Authors:  S Oparil; S Aronson; G M Deeb; M Epstein; J H Levy; R R Luther; R Prielipp; A Taylor
Journal:  Am J Hypertens       Date:  1999-07       Impact factor: 2.689

Review 6.  Role of FDG PET/CT in imaging of renal lesions.

Authors:  R Kochhar; R K Brown; C O Wong; N R Dunnick; K A Frey; P Manoharan
Journal:  J Med Imaging Radiat Oncol       Date:  2010-08       Impact factor: 1.735

7.  A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia.

Authors:  Darin D Dougherty; Jian Kong; Megan Webb; Ali A Bonab; Alan J Fischman; Randy L Gollub
Journal:  Behav Brain Res       Date:  2008-05-02       Impact factor: 3.332

8.  Public health consequences of chronic kidney disease.

Authors:  D E Weiner
Journal:  Clin Pharmacol Ther       Date:  2009-07-29       Impact factor: 6.875

Review 9.  Hypertension crisis in the emergency department.

Authors:  Wallace Johnson; My-Le Nguyen; Ronak Patel
Journal:  Cardiol Clin       Date:  2012-10-02       Impact factor: 2.213

Review 10.  Renal dopamine receptors and hypertension.

Authors:  Tahir Hussain; Mustafa F Lokhandwala
Journal:  Exp Biol Med (Maywood)       Date:  2003-02
View more
  3 in total

Review 1.  Antihypertensive mechanisms of intra-renal dopamine.

Authors:  Ming-Zhi Zhang; Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

2.  Neuroinflammatory component of gray matter pathology in multiple sclerosis.

Authors:  Elena Herranz; Costanza Giannì; Céline Louapre; Constantina A Treaba; Sindhuja T Govindarajan; Russell Ouellette; Marco L Loggia; Jacob A Sloane; Nancy Madigan; David Izquierdo-Garcia; Noreen Ward; Gabriel Mangeat; Tobias Granberg; Eric C Klawiter; Ciprian Catana; Jacob M Hooker; Norman Taylor; Carolina Ionete; Revere P Kinkel; Caterina Mainero
Journal:  Ann Neurol       Date:  2016-10-25       Impact factor: 10.422

3.  Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.

Authors:  Anissa Abi-Dargham; Jonathan A Javitch; Mark Slifstein; Alan Anticevic; Monica E Calkins; Youngsun T Cho; Clara Fonteneau; Roberto Gil; Ragy Girgis; Raquel E Gur; Ruben C Gur; Jack Grinband; Joshua Kantrowitz; Christian Kohler; John Krystal; John Murray; Mohini Ranganathan; Nicole Santamauro; Jared Van Snellenberg; Zailyn Tamayo; Daniel Wolf; David Gray; Jeffrey Lieberman
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.